Suppr超能文献

组蛋白去乙酰化酶抑制剂通过表观遗传促进原代牙髓细胞的修复事件。

Histone deacetylase inhibitors epigenetically promote reparative events in primary dental pulp cells.

机构信息

Division of Restorative Dentistry & Periodontology, Dublin Dental University Hospital, Trinity College Dublin, Lincoln Place, Dublin 2, Ireland.

出版信息

Exp Cell Res. 2013 Jun 10;319(10):1534-43. doi: 10.1016/j.yexcr.2013.02.022. Epub 2013 Apr 3.

Abstract

Application of histone deacetylase inhibitors (HDACi) to cells epigenetically alters their chromatin structure and induces transcriptional and cellular reparative events. This study investigated the application of two HDACi, valproic acid (VPA) and trichostatin A (TSA) on the induction of repair-associated responses in primary dental pulp cell (DPC) cultures. Flow cytometry demonstrated that TSA (100 nM, 400 nM) significantly increased cell viability. Neither HDACi was cytotoxic, although cell growth analysis revealed significant anti-proliferative effects at higher concentrations for VPA (>0.5 mM) and TSA (>50 nM). While high-content-analysis demonstrated that HDACi did not significantly induce caspase-3 or p21 activity, p53-expression was increased by VPA (3 mM, 5 mM) at 48 h. HDACi-exposure induced mineralization per cell dose-dependently to a plateau level (VPA-0.125 mM and TSA-25 nM) with accompanying increases in mineralization/dentinogenic-associated gene expression at 5 days (DMP-1, BMP-2/-4, Nestin) and 10 days (DSPP, BMP-2/-4). Both HDACis, at a range of concentrations, significantly stimulated osteopontin and BMP-2 protein expression at 10 and 14 days further supporting the ability of HDACi to promote differentiation. HDACi exert different effects on primary compared with transformed DPCs and promote mineralization and differentiation events without cytotoxic effects. These novel data now highlight the potential in restorative dentistry for applying low concentrations of HDACi in vital pulp treatment.

摘要

组蛋白去乙酰化酶抑制剂 (HDACi) 应用于细胞可在表观遗传学上改变其染色质结构,并诱导转录和细胞修复事件。本研究调查了两种 HDACi,即丙戊酸 (VPA) 和曲古抑菌素 A (TSA) 在诱导原代牙髓细胞 (DPC) 培养物修复相关反应中的应用。流式细胞术表明 TSA(100 nM, 400 nM) 可显著提高细胞活力。两种 HDACi 均无细胞毒性,但细胞生长分析显示 VPA(>0.5 mM) 和 TSA(>50 nM) 浓度较高时具有显著的抗增殖作用。虽然高内涵分析表明 HDACi 并未显著诱导 caspase-3 或 p21 活性,但 VPA(3 mM, 5 mM) 在 48 小时可增加 p53 表达。HDACi 暴露可使细胞剂量依赖性地增加矿化,直至达到平台水平(VPA-0.125 mM 和 TSA-25 nM),同时在 5 天(DMP-1、BMP-2/-4、Nestin)和 10 天(DSPP、BMP-2/-4)时增加矿化/牙本质形成相关基因表达。两种 HDACi 在一系列浓度下均可显著刺激骨桥蛋白和 BMP-2 蛋白表达,在 10 天和 14 天进一步支持 HDACi 促进分化的能力。HDACi 对原代和转化的 DPC 具有不同的作用,并在没有细胞毒性作用的情况下促进矿化和分化事件。这些新数据现在突出了在牙髓活力治疗中应用低浓度 HDACi 的潜力。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验